A Study of GZR18 Injection in Obese/Overweight Patients
Status:
COMPLETED
Trial end date:
2024-06-05
Target enrollment:
Participant gender:
Summary
This study is a multicenter, randomized, placebo-controlled phase II clinical study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of GZR18 injection in Chinese adult obese/overweight subjects.